Showing results (1171-1180 of 2,563) with videos related to

Sort By:
Pageof 257
Inflammopharmacology|October 16, 2023
The efficacy of thymosin alpha-1 therapy in moderate to critical COVID-19 patients: a systematic review, meta-analysis, and meta-regressionArto Yuwono Soeroto, Hendarsyah Suryadinata, Theo Audi Yanto, et al.
Inflammopharmacology|October 17, 2023
Protective effect of olopatadine hydrochloride against LPS-induced acute lung injury: via targeting NF-κB signaling pathwayJaspreet Kaur, Priyanka Rana, Tushar Matta, et al.
Inflammopharmacology|September 27, 2023
Salsalate: a pleotropic anti-inflammatory drug in the treatment of diabetes, obesity, and metabolic diseasesI Hasan, K D Rainsford, Joel S Ross
Inflammopharmacology|September 23, 2024
Essential oils: a potential alternative with promising active ingredients for pharmaceutical formulations in chronic wound managementPulukkunadu Thekkeveedu Roshni, Punchappady Devasya Rekha
Inflammopharmacology|September 21, 2024
A medicine and food homology formula prevents cognitive deficits by inhibiting neuroinflammation and oxidative stress via activating AEA-Trpv1-Nrf2 pathwayMing-Jie Li, Jing-Yi Xu, Hua-Yue Zhang, et al.
Inflammopharmacology|June 1, 2023
Beneficial effects of flavonoids on cardiovascular diseases by influencing NLRP3 inflammasomeHai-Yan Fang, Xiao-Ni Zhao, Meng Zhang, et al.
Inflammopharmacology|March 2, 2026
Comparative efficacy of transdermal buprenorphine versus diclofenac in the management of knee osteoarthritis: a randomized controlled trial with network pharmacology insightsAbhay Singh, Sneha Yadav, Anil Kumar Gulia, et al.
Inflammopharmacology|March 5, 2026
Trientine ameliorates bleomycin-induced pulmonary fibrosis in rats through copper chelation and modulation of the CTR1/LOX/COL pathwayIbrahim T Khalil, Mahmoud Elshal, Norhan M Elsayed, et al.
Inflammopharmacology|March 3, 2026
A novel oral interleukin-23 receptor antagonist peptide, icotrokinra, for moderate-to- severe plaque psoriasis: a systematic review and meta-analysis of randomized controlled trialsMartin Cevallos-Cueva, Chinenye Onejeme, Laura Ghanem, et al.
Inflammopharmacology|February 21, 2026
Intrarectal delivery of chitosan hydrogel-encapsulated mesenchymal stem cell-conditioned media attenuates disease severity in experimental ulcerative colitisHossein Mokhtari, Mostafa Haji Molla Hoseini, Seyed Mahmoud Hashemi, et al.
Pageof 257